Obstructive sleep apnea linked with higher risk of gout

August 30, 2018

New research reveals that people with obstructive sleep apnea (OSA) have a higher risk of developing gout, even beyond the first years after being diagnosed with the sleep disorder. The findings are published in Arthritis & Rheumatology, an official journal of the American College of Rheumatology.

OSA is associated with a range of serious comorbidities, and it has previously been shown that people with OSA have a higher risk of developing gout in the first year after diagnosis. To investigate whether they may also be more likely to develop gout over a longer term, a team led by Edward Roddy, DM and Milica Blagojevic-Bucknall, PhD, of Keele University in the UK, examined information on 15,879 patients with OSA and 63,296 without, with a median follow-up of 5.8 years.

During follow-up. 4.9% of OSA and 2.6% of non-OSA patients developed gout. Incidence rates per 1000 person-years were 7.83 and 4.03 among those with and without OSA, respectively, for a 42% increased risk among OSA patients. (A person-year is the number of years of follow-up multiplied by the number of people in the analysis.)

An elevated risk of developing gout was observed throughout follow-up for OSA patients, but it was highest one to two years after diagnosis of OSA. This finding was seen in patients with normal body mass index as well as those who were overweight or obese; however, the risk was greater in those with normal weight.

"People with sleep apnoea are at an increased risk of gout in both the short and long term. Since this risk was highest in people with normal body mass index, doctors and other health professionals should consider the possibility of gout in patents with sleep apnoea regardless of body mass index," said Dr. Roddy.

It's thought that intermittent oxygen deficiency due to OSA leads to over- production of uric acid, which causes gout. "Sleep apnea is commonly treated with continuous positive airways pressure--or CPAP--therapy. Since CPAP treatment corrects low oxygen levels it might also be expected to reduce uric acid levels, which could possibly reduce the risk of developing gout or treat existing gout; however, further research is needed to investigate the effect of treatment with CPAP in people with gout," said Dr. Blagojevic-Bucknall.
-end-
Additional Information

The information contained in this release is protected by copyright. Members of the media may sign up for embargoed news or to request a copy of any study please contact:

Dawn Peters (US) +1 781-388-8408
sciencenewsroom@wiley.com

Follow us on Twitter @WileyNews

Full Citation

"Gout as a consequence of obstructive sleep apnea: a matched cohort study." Milica Blagojevic-Bucknall, Christian Mallen, Sara Muller, Richard Hayward, Sophie West, Hyon Choi, and Edward Roddy. Arthritis & Rheumatology; Published Online: August 30, 2018 (DOI: 10.1002/art.40662).

URL Upon Publication: http://doi.wiley.com/10.1002/art.40662

About the Journal

Arthritis & Rheumatology is an official journal of the American College of Rheumatology (ACR) and covers all aspects of inflammatory disease. The American College of Rheumatology (http://www.rheumatology.org) is the professional organization whose members share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. The journal is published by Wiley on behalf of the ACR. For more information, please visit http://wileyonlinelibrary.com/journal/art.

About Wiley

Wiley is a global leader in education and scholarly research. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

Wiley

Related Sleep Apnea Articles from Brightsurf:

Sleep apnea may be risk factor for COVID-19
The question of sleep apnea as the risk factor for COVID-19 arose in a study conducted by the Turku University Hospital and the University of Turku on patients of the first wave of the pandemic.

Untreated sleep apnea is associated with flu hospitalization
As we approach flu season, adults with obstructive sleep apnea may want to take extra precautions.

Losing tongue fat improves sleep apnea
Using magnetic resonance imaging (MRI) to measure the effect of weight loss on the upper airway in obese patients, researchers found that reducing tongue fat is a primary factor in lessening the severity of OSA.

More cancer cases among women with sleep apnea
Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows.

New evidence on the association of shortened sleep time and obstructive sleep apnea with sleepiness and cardiometabolic risk factors
A new study in the journal CHEST® may change the way we think about sleep disorders.

Synthetic cannabis-like drug reduces sleep apnea
A synthetic cannabis-like drug in a pill reduced apnea and daytime sleepiness in the first large multi-site study of a drug for apnea.

Inflammation may precede sleep apnea, could be treatment target
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

Concerns that sleep apnea could impact healthspan
The number of people with obstructive sleep apnea has steadily increased over the past two decades.

Sleep apnea and insomnia combination linked with depression
A new study found that men with sleep apnea and insomnia have a higher prevalence and severity of depressive symptoms than men with sleep apnea or insomnia alone.

Anti-nausea drug could help treat sleep apnea
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.

Read More: Sleep Apnea News and Sleep Apnea Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.